Home › Compare › Cagrilintide vs Retatrutide
Cagrilintide vs Retatrutide
Cagrilintide and Retatrutide are both metabolic / weight loss peptides, which is why they get recommended interchangeably — but they are different compounds with different origins. The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
CagrilintideMetabolic / Weight Loss
RetatrutideMetabolic / Weight LossAt a glance
| Cagrilintide | Retatrutide | |
|---|---|---|
| Category | Metabolic / Weight Loss | Metabolic / Weight Loss |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Appetite suppression Fullness Fat loss (esp. with GLP-1) | Extreme fat loss Increased energy expenditure Metabolic reset |
| Reported considerations | Nausea Injection site reaction | Severe GI distress if titrated fast Elevated heart rate |
The differences that actually matter
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Where they overlap: fat loss (esp. with glp-1).
Reported mainly for Cagrilintide: appetite suppression, fullness.
Reported mainly for Retatrutide: increased energy expenditure, metabolic reset.
What Cagrilintide is
Cagrilintide is a synthetic, long-acting analog of the naturally occurring hormone amylin, which is co-secreted with insulin from pancreatic beta cells. It primarily functions by activating amylin receptors, which are complexes of the calcitonin receptor with receptor activity-modifying proteins (RAMPs 1, 2, or 3), found in various tissues, including the brain. Through this mechanism, cagrilintide influences satiety centers in the hypothalamus and slows the rate of gastric emptying, thereby reducing post-meal gluco
What Retatrutide is
Retatrutide is an investigational peptide that operates as a triple agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. By activating these three distinct receptors, retatrutide is understood to influence multiple metabolic pathways, including glucose regulation, appetite control, and energy expenditure. The activation of GLP-1 and GIP receptors generally promotes glucose-dependent insulin secretion and slows gastric emptying, while glu
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Cagrilintide and Retatrutide are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Cagrilintide and Retatrutide?
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log Cagrilintide and Retatrutide in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Cagrilintide or Retatrutide?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.